Nothing on this Website should be construed as the giving of advice or the making of a recommendation regarding any decision or action related to your health or the health of others. If you are a patient, you should consult a doctor or other qualified healthcare professional regarding any questions you have about your health or before making any treatment decisions. If you are a doctor or other qualified healthcare professional, you should not allow the information on this Website to substitute for your own medical judgment, which you should exercise in evaluating the information on this Website.
To the extent applicable, this Website may include “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements may be identified by the use of words like “anticipate,” “believe,” “estimate,” “expect,” “intend,” “may,” “plan,” “potential,” “will,” “should,” “seek,” and similar expressions. The forward-looking statements reflect our views and assumptions with respect to future events as of the date of this document and are subject to risks and uncertainties. Actual and future results and trends could differ materially from those described by such statements due to various factors that are beyond our ability to control or predict. Given these uncertainties, you should not place undue reliance on the forward-looking statements. Proteovant does not undertake any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
Proteovant may terminate, change, suspend or discontinue any aspect of this Website, including the availability of any features of this Website, at any time. Proteovant may also impose limits on certain features and services or restrict your access to parts of or the entire Website without notice or liability.
Proteovant Intellectual Property
This Website is protected by applicable law. The contents of this Website, including, but not limited to, text, names, data, compilations, graphics, logos, buttons, icons, images, audio, video, code, methods, techniques, models, and software (the “Contents”), are the property of Proteovant and/or its subsidiaries, affiliates and licensors and are protected by the patent, copyright, trademark and trade secret laws of the United States and other countries. You should assume that everything you see or read on this Website is copyrighted. You shall not reproduce, display, distribute, modify, transmit, reuse, repost, or otherwise use any Content without the express written permission of Proteovant. You shall not frame or deep link to the Content or this Website for any purpose without the express written permission of Proteovant.
The trademarks, service marks and logos appearing on this Website (“Trademarks”) are the property of Proteovant and/or its subsidiaries, affiliates and licensors. This Website may also contain or reference patents, trade secrets, proprietary information, technologies, products, processes, or other proprietary rights of Proteovant and/or other parties. No license to, or right in, any such Trademarks, patents, trade secrets, proprietary information, technologies, products, processes, and other proprietary rights of Proteovant and/or other parties is granted to, or conferred upon, you.
No Warranties or Liability
THIS WEBSITE AND ALL INFORMATION ON THIS WEBSITE IS PROVIDED TO YOU ON AN “AS IS,” “AS AVAILABLE” BASIS. PROTEOVANT HEREBY DISCLAIMS ALL WARRANTIES OF ANY KIND, EXPRESS OR IMPLIED, INCLUDING, BUT NOT LIMITED TO, THE IMPLIED WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, AND NON-INFRINGEMENT.
IN NO EVENT SHALL PROTEOVANT OR ITS SUBSIDIARIES OR AFFILIATES, ANY OF THEIR LICENSORS OR ANY OF THEIR RESPECTIVE OFFICERS, DIRECTORS, EMPLOYEES OR AGENTS BE LIABLE TO YOU FOR ANY CLAIM ARISING OUT OF OR RELATING TO YOUR USE OF THE WEBSITE OR INFORMATION ON THIS WEBSITE.
Links to Other Websites
Your User Content and Communications
Our Website may allow users to post, submit, or display information, messages, suggestions, questions, comments, postings, advertisements, ratings, ideas, techniques, notes, know-how, drawings, concepts, designs, audiovisual material, photographs and pictures (including pictures of the user and other representations of the user’s name and likeness), digital images, or other content in any form (collectively “User Content”). It is the responsibility of the individual providing such User Content to ensure that no portion of the content is illegal, obscene, threatening, defamatory, invasive of privacy, infringing of intellectual property rights or otherwise injurious to third parties.
By posting User Content on this Website, you hereby grant Proteovant an unrestricted, transferable, sub-licensable, irrevocable, royalty-free, worldwide, and perpetual license to reproduce, distribute, publicly display, make derivative works of, and otherwise use the User Content in any media whatsoever now known or later invented throughout the world for any purpose whatsoever, commercial or not. You hereby disclaim any right to any compensation from Proteovant in connection with Proteovant’s exercise of its license rights in and to the User Content you have posted on this Website. You acknowledge and agree that Proteovant is under no obligation of confidence to you, and shall not be liable for any use or disclosure of any User Content. By posting the User Content on this Website, you represent and warrant that you own the copyright in such User Content or that you have a legitimate license to post the User Content without any restrictions whatsoever. You agree to indemnify, defend and hold Proteovant harmless from all actual and incidental costs and fees associated with Proteovant’s defense of any claims arising from User Content, including, but not limited to, all attorneys’ fees.
Proteovant reserves the right to review any User Content and remove, delete, redact, or otherwise modify such User Content, in its sole discretion, at any time and from time to time, without notice or further obligation to you. Proteovant has no obligation to display or post any User Content. Proteovant reserves the right to disclose, at any time and from time to time, any information or User Content that Proteovant deems necessary or appropriate to satisfy any applicable law, regulation, contractual obligation, legal dispute process, or governmental request. Proteovant shall have no liability in connection with any User Content submitted to, transmitted via, or displayed or posted on this Website.
Proteovant is committed to respecting others’ intellectual property rights, and we ask our users to do the same. Proteovant may, in its sole discretion, terminate the accounts or access rights of users who violate others’ intellectual property rights. If you believe that your work has been copied in a way that constitutes copyright infringement on this Website, please deliver the following information to Proteovant’s Copyright Agent:
An electronic or physical signature of the person authorized to act on behalf of the copyright owner
A description of the copyrighted work that you claim has been infringed
A description of where the material that you claim is infringing is located on our Website
Your address, telephone number, and e-mail address so that we may contact you
A statement by you that you have a good faith belief that the disputed use is not authorized by the copyright owner, its agent, or the law
A statement by you, made under penalty of perjury, that the information in your notice to us is accurate and that you are the copyright owner or authorized to act on the copyright owner’s behalf
Proteovant’s Copyright Agent for notice of claims of copyright infringement on this Website can be reached at Oncopia Therapeutics, Inc d/b/a Proteovant Therapeutics, Inc., Legal and Compliance Department, 151 W 42nd St. 15th floor, New York, NY 10036. A copy of the notice and supporting materials should also be submitted electronically to email@example.com.
Governing Law and Jurisdiction
This Terms of Service is effective as of: September 15, 2021.